Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARTERIAL VASCULAR ENGINEERING -- Ignore unavailable to you. Want to Upgrade?

To: Jeff Gurian who wrote (310)	11/26/1997 1:09:00 PM
From: Zeus549	Read Replies (1) \| Respond to of 339

Jeff, I was taken a little by suprise by the earnings adjustment, but only from the point of view that there was as much movement from it as there was. I had already figured in about $2 per share and discounted it. I doubt I'm the only one in that category. The TA still shows some weakness with yesterday actually being slightly on the distribution side even though the price went up. My projections for retreats to the 40's are relatively short term predictions. As you may recall I did a long term projection on AVEI based on the total US market for stents and AVEI garnering about 30% of that market. On that basis I had a price target of about $75 dollars. I think there is going to be a lot of resistance in the low $60's. Therefore I think that we will hang in this mid 40's to mid 50's level for a while at least. A nice Thanksgiving to you also.